ANIXA BIOSCIENCES, INC. Earnings Per Share (Diluted)
ANIXA BIOSCIENCES, INC. (ANIX) reported Earnings Per Share (Diluted) of -$0.08 per share for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2026-07-31 was -$0.08.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2026-04-30 was -$0.07.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2026-01-31 was -$0.08.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2025-10-31 was $0.03, a 7.94% decline year-over-year.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for fiscal 2025 was -$0.34.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for fiscal 2024 was -$0.39.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for fiscal 2023 was -$0.32, a 171.11% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. earnings per share, diluted for fiscal 2022 was $0.45.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$0.08 10-Q · filed 2026-09-09 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-09-09 | -$0.23 10-Q · filed 2026-09-09 | -$9.74 derived: net income ÷ weighted average shares · filed 2026-09-09 | |||
| 2026-04-30 | -$0.07 10-Q · filed 2026-06-10 | -$0.15 10-Q · filed 2026-06-10 | $0.78 derived: net income ÷ weighted average shares · filed 2026-06-10 | -$15.68 derived: net income ÷ weighted average shares · filed 2026-09-09 | |||
| 2026-01-31 | -$0.08 10-Q · filed 2026-03-09 | $0.17 derived: net income ÷ weighted average shares · filed 2026-03-09 | $0.73 derived: net income ÷ weighted average shares · filed 2026-09-09 | -$35.28 derived: net income ÷ weighted average shares · filed 2026-09-09 | |||
| 2025-10-31 | $0.03 derived: net income ÷ weighted average shares · filed 2026-01-12 | $0.15 derived: net income ÷ weighted average shares · filed 2026-09-09 | $0.72 derived: net income ÷ weighted average shares · filed 2026-09-09 | -$0.34 10-K · filed 2026-01-12 | |||
| 2025-07-31 | -$0.07 10-Q · filed 2026-09-09 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-09-09 | -$0.25 10-Q · filed 2026-09-09 | -$27.95 derived: net income ÷ weighted average shares · filed 2026-09-09 | |||
| 2025-04-30 | -$0.09 10-Q · filed 2026-06-10 | -$0.19 10-Q · filed 2026-06-10 | $0.86 derived: net income ÷ weighted average shares · filed 2026-06-10 | -$41.53 derived: net income ÷ weighted average shares · filed 2026-06-10 | |||
| 2025-01-31 | -$0.10 10-Q · filed 2026-03-09 | $0.19 derived: net income ÷ weighted average shares · filed 2026-03-09 | $0.90 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$56.70 derived: net income ÷ weighted average shares · filed 2026-03-09 | |||
| 2024-10-31 | $0.03 derived: net income ÷ weighted average shares · filed 2026-01-12 | $0.19 derived: net income ÷ weighted average shares · filed 2026-01-12 | $0.89 derived: net income ÷ weighted average shares · filed 2026-01-12 | -$0.39 10-K · filed 2026-01-12 | |||
| 2024-07-31 | -$0.10 10-Q · filed 2025-09-10 | -$0.20 derived: net income ÷ weighted average shares · filed 2025-09-10 | -$0.30 10-Q · filed 2025-09-10 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-09-10 | |||
| 2024-04-30 | -$0.10 10-Q · filed 2025-05-28 | -$0.20 10-Q · filed 2025-05-28 | -$0.43 derived: net income ÷ weighted average shares · filed 2025-05-28 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-05-28 | |||
| 2024-01-31 | -$0.10 10-Q · filed 2025-03-11 | $0.10 10-Q · filed 2024-03-12 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$1.36 derived: net income ÷ weighted average shares · filed 2025-03-11 | ||
| 2023-10-31 | -$86.50 derived: net income ÷ weighted average shares · filed 2025-01-10 | -$167.58 derived: net income ÷ weighted average shares · filed 2025-01-10 | -$241.58 derived: net income ÷ weighted average shares · filed 2025-01-10 | -$0.32 10-K · filed 2025-01-10 | $0.32 10-K · filed 2024-01-16 | ||
| 2023-07-31 | -$0.08 10-Q · filed 2024-09-06 | -$155.05 derived: net income ÷ weighted average shares · filed 2024-09-06 | -$0.23 10-Q · filed 2024-09-06 | -$342.98 derived: net income ÷ weighted average shares · filed 2024-09-06 | |||
| 2023-04-30 | -$0.07 10-Q · filed 2024-06-04 | -$0.15 10-Q · filed 2024-06-04 | -$261.92 derived: net income ÷ weighted average shares · filed 2024-06-04 | -$352.07 derived: net income ÷ weighted average shares · filed 2024-06-04 | |||
| 2023-01-31 | $0.08 10-Q · filed 2024-03-12 | -$187.99 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$278.20 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$395.39 derived: net income ÷ weighted average shares · filed 2024-03-12 | |||
| 2022-10-31 | -$112.99 derived: net income ÷ weighted average shares · filed 2024-01-16 | -$203.28 derived: net income ÷ weighted average shares · filed 2024-01-16 | -$320.66 derived: net income ÷ weighted average shares · filed 2024-01-16 | $0.45 10-K · filed 2024-01-16 | |||
| 2022-07-31 | -$0.09 10-Q · filed 2023-09-06 | -$207.58 derived: net income ÷ weighted average shares · filed 2023-09-06 | -$0.33 10-Q · filed 2023-09-06 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-09-06 | |||
| 2022-04-30 | -$117.54 derived: net income ÷ weighted average shares · filed 2023-06-14 | -$244.64 derived: net income ÷ weighted average shares · filed 2023-06-14 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-06-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2023-06-14 | |||
| 2022-01-31 | -$127.10 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-03-17 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-03-17 | |||
| 2021-10-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2023-01-04 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-01-04 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-01-04 | -$0.45 derived: net income ÷ weighted average shares · filed 2023-01-04 | |||
| 2021-07-31 | -$142.31 derived: net income ÷ weighted average shares · filed 2022-09-09 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-09-09 | -$318.30 derived: net income ÷ weighted average shares · filed 2022-09-09 | ||||
| 2021-04-30 | -$0.08 derived: net income ÷ weighted average shares · filed 2022-06-10 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-06-10 | |||||
| 2021-01-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-03-11 | ||||||
| 2018-04-30 | -$0.08 10-Q · filed 2018-06-11 | ||||||
| 2017-04-30 | $0.02 10-Q · filed 2018-06-11 | ||||||
| 2016-04-30 | -$0.15 10-Q · filed 2017-05-26 | -$0.33 10-Q · filed 2016-05-20 | |||||
| 2016-01-31 | -$0.18 10-Q · filed 2016-02-19 | ||||||
| 2015-07-31 | -$0.18 10-Q · filed 2015-08-18 | -$0.41 derived: net income ÷ weighted average shares · filed 2016-08-19 | -$0.01 derived: net income ÷ weighted average shares · filed 2016-08-19 | ||||
| 2015-04-30 | -$0.22 derived: net income ÷ weighted average shares · filed 2016-05-20 | $0.16 10-Q · filed 2016-05-20 | $0.01 10-Q · filed 2015-05-22 | ||||
| 2015-01-31 | $0.41 10-Q · filed 2016-02-19 | $0.02 10-Q · filed 2015-03-09 | |||||
| 2014-07-31 | $0.04 10-Q · filed 2015-08-18 | -$0.03 derived: net income ÷ weighted average shares · filed 2015-08-18 | -$0.04 derived: net income ÷ weighted average shares · filed 2015-08-18 | ||||
| 2014-04-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2015-05-22 | -$0.03 10-Q · filed 2015-05-22 | |||||
| 2014-01-31 | -$0.02 10-Q · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |